Chief Scientific Officer

Main responsibilities:

·Plans, builds, evolves and maintains a highly functional, compliant and external oriented Medical Affairs organization. Managing flexible and efficient resource deployment and utilization.

·Ensures compliance with S.I. No. 541/2007 - Medicinal Products (Control of Advertising) Regulations 2007 and the IPHA Code of Practice as well as Novartis Doing Business Ethically Policy and Novartis Code of Ethics.

·Raises country medical and clinical interests into global and WEC Cluster, Regional and Global strategy and planning prelaunch, through providing timely and strategic feedback to GPTs. This shapes the development program earlier and ensures IDPs include integrated, diverse data available at launch to support own local reimbursement and clinical implementation.

·Drives earlier initiation of integrated evidence generation strategies, novel research activities, and local collaborative and impactful partnership engagements. Supports utility of RWE innovative study designs and exploratory trials (where applicable) across TAs to accelerate patient access; oversight of MAPs, IITs etc.

·In line with the evolving healthcare ecosystem, proactively and strategically builds and strengthens partnerships beyond the traditional HCPs and organisations. Identifies opportunities for joint value creation deploying new engagement models of broader reach.

·Engages with key patient associations, academic societies, patients, payers and reimbursement bodies as well as the relevant healthcare systems, to harness opportunities and share ownership in transforming the clinical practice with optimal access and better outcomes for real world patients.

·In close collaboration with Drug Development (DD), cultivates strategic and effective co- creation and collaboration plans, for allocation and execution of clinical trials within the country, as necessary.

·Ensures compliance approval for events/ materials used by various functions within Novartis Ireland is in place

communication plans in place for external stakeholder education and advocacy.

·Ensures implementation science plans are in place early to systematically shape health policy and practice guidelines converging clinical innovations and treatments into better standards of care via better disease management.

·Has an in-depth understanding of local healthcare ecosystem and contextual system challenges to ensure early reimbursement and patient adherence.

·Encourages utility of more innovative digital technologies for more meaningful and impactful engagements and data generation and utilization.

·Builds and facilitates close cross-functional equal partner collaborations with key internal stakeholders, co-creating and leading where necessary.

·Function as the key medical interface to Country President, Value & Access, TA Heads and BE&E Heads, Public Affairs and Compliance teams as well as related Cluster, Regional and Global teams. In partnership with country Regulatory Affairs, develops and manages long-term relationships with HPRA and relevant medical societies.

·Maintains and drives the standards of medical and scientific excellence in the country through recruitment selection, deployment and capability upskilling of agile innovative and collaborative talent together with P&O, in accordance with Novartis Leadership Standards.

·Role models ethical standards and contribute proactively to a credible image for Novartis in the country.

·Represent Novartis at key external scientific, clinical, and medical events to educate, advocate and support innovation and evidence-based research.

·Owns and optimizes medical resources and allocation: Advocates early resourcing (where and when appropriate), while ensuring cost adherence in spend of Medical Affairs trials, activities, and resourcing. Ability to articulate and defend priorities and needs of medical with strong influencing skills. Recruits, hires and develops talent while maximizing potential for leadership.

Experience:

· 10+ years of relevant experience working with high-performing medical and access teams in healthcare/life sciences industry.

· Relevant experience acquired at pharmaceutical companies, HTA, physician associations or health care consultancy companies or equivalent experience.

· Working knowledge of pharmaceutical market and healthcare systems.

· Proven ability to collaborate, operate and influence cross-functionally, trans-nationally and cross-culturally in a complex and international matrix environment. Strong business acumen

· Proven ability to network with all levels of external stakeholders and work in matrix environment distilling and prioritizing market needs and deliverables.

· Scientific/medical research experience with demonstrated record of scientific/medical publication desirable.and local country and/or cross country study planning and execution experience

· Excellent understanding of local, regional, and country regulatory standards and processes, as well as relevant ethical and legal guidelines. International/global experience desirable.

· Significant experience of risk management.

· Strong leadership and influencing skills in a matrix; articulate vision for MA in the Country; build externally focused culture.

· Excellent writing, communication, and interpersonal skills.

· Strong solution-orientation and business acumen.

· Operate with mutual respect and integrity, embrace diversity, collaboration and diversity and collaboration.

· Deep understanding of drug development and approval processes, including experience designing and/or executing clinical studies.

· Thought leader in all medical core and game changing competencies.

· Result focus with high integrity.

· Ability to work in a high paced and changing environment.

· Self-starter with proactive working style.

· Strong oral and written communication skills.